Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q40609546 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241020233020.0 | ||
| 008 | 241020nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q40609546 | ||
| 024 | ‡a 0000-0002-8887-6087 ‡2 orcid | ||
| 024 | ‡a 56939793900 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q40609546 | ||
| 100 | 0 | ‡a José Moreno ‡9 fr ‡9 nn ‡9 ast ‡9 is ‡9 de ‡9 sv ‡9 da ‡9 sl ‡9 kl ‡9 nb ‡9 es ‡9 fo | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a José Moreno ‡c life science researcher ‡9 en | |
| 400 | 0 | ‡a José Moreno ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A polymorphism in the AT-hook motif of the transcriptional regulator AKNA is a risk factor for cervical cancer | ||
| 670 | ‡a Author's Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients. | ||
| 670 | ‡a Author's Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain | ||
| 670 | ‡a Author's B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner | ||
| 670 | ‡a Author's CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. | ||
| 670 | ‡a Author's CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation | ||
| 670 | ‡a Author's Cell-mediated immunity to myoglobin in polymyositis | ||
| 670 | ‡a Author's Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus | ||
| 670 | ‡a Author's Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice | ||
| 670 | ‡a Author's Does CD4 help to maintain the fidelity of T cell receptor specificity? | ||
| 670 | ‡a Author's Does CD40 ligation induce B cell negative selection? | ||
| 670 | ‡a Author's Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation. | ||
| 670 | ‡a Author's Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments | ||
| 670 | ‡a Author's Enhanced healing and anti-inflammatory effects of a carbohydrate polymer with zinc oxide in patients with chronic venous leg ulcers: preliminary results. | ||
| 670 | ‡a Author's Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells. | ||
| 670 | ‡a Author's Functional heterogeneity of human antigen-presenting cells: presentation of soluble antigen but not self-Ia by monocytes | ||
| 670 | ‡a Author's Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways | ||
| 670 | ‡a Author's [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes]. | ||
| 670 | ‡a Author's HPV16-E6 Oncoprotein Activates TGF-β and Wnt/β-Catenin Pathways in the Epithelium-Mesenchymal Transition of Cataracts in a Transgenic Mouse Model. | ||
| 670 | ‡a Author's Human endotoxin tolerance is associated with enrichment of the CD14+ CD16+ monocyte subset | ||
| 670 | ‡a Author's In vitro drug metabolism testing using blood-monocyte derivatives. | ||
| 670 | ‡a Author's Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer. | ||
| 670 | ‡a Author's Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs | ||
| 670 | ‡a Author's Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus | ||
| 670 | ‡a Author's Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence | ||
| 670 | ‡a Author's Prevotella copri and the microbial pathogenesis of rheumatoid arthritis | ||
| 670 | ‡a Author's Reconstructing and mining the B cell repertoire with ImmunediveRsity | ||
| 670 | ‡a Author's Rheumatic manifestations of human immunodeficiency virus infection | ||
| 670 | ‡a Author's Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis. | ||
| 670 | ‡a Author's Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules | ||
| 670 | ‡a Author's Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer. | ||
| 670 | ‡a Author's The PDZ-Binding Motif of HPV16-E6 Oncoprotein Modulates the Keratinization and Stemness Transcriptional Profile In Vivo | ||
| 670 | ‡a Author's The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population. | ||
| 670 | ‡a Author's The relationship between the antitumor effect of the IL-12 gene therapy and the expression of Th1 cytokines in an HPV16-positive murine tumor model. | ||
| 670 | ‡a Author's [Toward a non-empirical treatment for rheumatoid arthritis based on its molecular pathology] | ||
| 670 | ‡a Author's Two Novel FAM20C Variants in A Family with Raine Syndrome | ||
| 670 | ‡a Author's Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8+ cytotoxic response and impairs the growth of E1-expressing tumors | ||
| 909 | ‡a (scopus) 56939793900 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000288876087 ‡9 1 | ||
| 919 | ‡a rheumaticmanifestationsofhumanimmunodeficiencyvirusinfection ‡A Rheumatic manifestations of human immunodeficiency virus infection ‡9 1 | ||
| 919 | ‡a doescd4helptomaintainthefidelityoftcellreceptorspecificity ‡A Does CD4 help to maintain the fidelity of T cell receptor specificity? ‡9 1 | ||
| 919 | ‡a 2novelfam20cvariantsinafamilywithrainesyndrome ‡A Two Novel FAM20C Variants in A Family with Raine Syndrome ‡9 1 | ||
| 919 | ‡a ptpn22r263qpolymorphismconfersprotectionagainstsystemiclupuserythematosusandrheumatoidarthritiswhileptpn22r620wconferssusceptibilitytogravesdiseaseinamexicanpopulation ‡A The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population. ‡9 1 | ||
| 919 | ‡a vaccinationwithhumanpapillomavirus18e1proteinplusαgalactosylceramideinducescd8+cytotoxicresponseandimpairsthegrowthofe1expressingtumors ‡A Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8+ cytotoxic response and impairs the growth of E1-expressing tumors ‡9 1 | ||
| 919 | ‡a relationshipbetweentheantitumoreffectoftheil12genetherapyandtheexpressionofth1cytokinesinanhpv16positivemurinetumormodel ‡A The relationship between the antitumor effect of the IL-12 gene therapy and the expression of Th1 cytokines in an HPV16-positive murine tumor model. ‡9 1 | ||
| 919 | ‡a towardanonempiricaltreatmentforrheumatoidarthritisbasedonitsmolecularpathology ‡A [Toward a non-empirical treatment for rheumatoid arthritis based on its molecular pathology] ‡9 1 | ||
| 919 | ‡a pdzbindingmotifofhpv16e6oncoproteinmodulatesthekeratinizationandstemnesstranscriptionalprofileinvivo ‡A The PDZ-Binding Motif of HPV16-E6 Oncoprotein Modulates the Keratinization and Stemness Transcriptional Profile In Vivo ‡9 1 | ||
| 919 | ‡a serumsubstancepanindicatorofdiseaseactivityandsubclinicalinflammationinrheumatoidarthritis ‡A Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis. ‡9 1 | ||
| 919 | ‡a reconstructingandminingthebcellrepertoirewithimmunediversity ‡A Reconstructing and mining the B cell repertoire with ImmunediveRsity ‡9 1 | ||
| 919 | ‡a prevotellacopriandthemicrobialpathogenesisofrheumatoidarthritis ‡A Prevotella copri and the microbial pathogenesis of rheumatoid arthritis ‡9 1 | ||
| 919 | ‡a lackofassociationbetweenhyperprolactinemiaandsolubleil2receptorlevelsinsystemiclupuserythematosus ‡A Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus ‡9 1 | ||
| 919 | ‡a macrophageandtlymphocyteapoptosisduringexperimentalpulmonarytuberculosistheirrelationshiptomycobacterialvirulence ‡A Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence ‡9 1 | ||
| 919 | ‡a increasedexpressionoffakisoformsaspotentialcancerbiomarkersinovariancancer ‡A Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer. ‡9 1 | ||
| 919 | ‡a humanendotoxintoleranceisassociatedwithenrichmentofthecd14+cd16+monocytesubset ‡A Human endotoxin tolerance is associated with enrichment of the CD14+ CD16+ monocyte subset ‡9 1 | ||
| 919 | ‡a globalexpressionanalysisinuterinecervicalcancermetabolicpathwaysandalteredgenes ‡A [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes]. ‡9 1 | ||
| 919 | ‡a hpv16e6oncoproteinactivatestgfβandwntβcateninpathwaysintheepitheliummesenchymaltransitionofcataractsinatransgenicmousemodel ‡A HPV16-E6 Oncoprotein Activates TGF-β and Wnt/β-Catenin Pathways in the Epithelium-Mesenchymal Transition of Cataracts in a Transgenic Mouse Model. ‡9 1 | ||
| 919 | ‡a genomewideexpressionanalysisinhpv16cervicalcanceridentificationofalteredmetabolicpathways ‡A Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways ‡9 1 | ||
| 919 | ‡a functionalheterogeneityofhumanantigenpresentingcellspresentationofsolubleantigenbutnotselfiabymonocytes ‡A Functional heterogeneity of human antigen-presenting cells: presentation of soluble antigen but not self-Ia by monocytes ‡9 1 | ||
| 919 | ‡a endogenousandexogenousformsofthesameantigenareprocessedfromdifferentpoolstobindmhcclass2moleculesinendocyticcompartments ‡A Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments ‡9 1 | ||
| 919 | ‡a exogenouspeptidescompeteforthepresentationofendogenousantigenstomajorhistocompatibilitycomplexclass2restrictedtcells ‡A Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells. ‡9 1 | ||
| 919 | ‡a enhancedhealingandantiinflammatoryeffectsofacarbohydratepolymerwithzincoxideinpatientswithchronicvenouslegulcerspreliminaryresults ‡A Enhanced healing and anti-inflammatory effects of a carbohydrate polymer with zinc oxide in patients with chronic venous leg ulcers: preliminary results. ‡9 1 | ||
| 919 | ‡a dynamicchangesintheintracellularassociationofselectedrabsmallgtpaseswithmhcclass2anddmduringdendriticcellmaturation ‡A Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation. ‡9 1 | ||
| 919 | ‡a cd40inducedaggregationofmhcclass2andcd80onthecellsurfaceleadstoanearlyenhancementinantigenpresentation ‡A CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation ‡9 1 | ||
| 919 | ‡a cytotoxictlymphocyterecognitionofhlaa2antigensinnormalandhlacw3transgenicmice ‡A Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice ‡9 1 | ||
| 919 | ‡a doescd40ligationinducebcellnegativeselection ‡A Does CD40 ligation induce B cell negative selection? ‡9 1 | ||
| 919 | ‡a constitutivephosphorylationofinterferonreceptoraassociatedsignalingproteinsinsystemiclupuserythematosus ‡A Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus ‡9 1 | ||
| 919 | ‡a bcellscanprimenaivecd4+tcellsinvivointheabsenceofotherprofessionalantigenpresentingcellsinacd154cd40dependentmanner ‡A B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner ‡9 1 | ||
| 919 | ‡a invitrodrugmetabolismtestingusingbloodmonocytederivatives ‡A In vitro drug metabolism testing using blood-monocyte derivatives. ‡9 1 | ||
| 919 | ‡a intradermalimmunizationintheearwithcholeratoxinanditsnontoxicβsubunitpromotesefficientth1andth17differentiationdependentonmigratingdcs ‡A Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs ‡9 1 | ||
| 919 | ‡a cellmediatedimmunitytomyoglobininpolymyositis ‡A Cell-mediated immunity to myoglobin in polymyositis ‡9 1 | ||
| 919 | ‡a antigenpresentationofheneggwhitelysozymebutnotofribonucleaseaisaugmentedbythemajorhistocompatibilitycomplexclass2associatedinvariantchain ‡A Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain ‡9 1 | ||
| 919 | ‡a cd3zetaexpressionandtcellproliferationareinhibitedbytgfbeta1andil10incervicalcancerpatients ‡A CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. ‡9 1 | ||
| 919 | ‡a alteredexpressionofnaturalcytotoxicityreceptorsandnkg2donperipheralbloodnkcellsubsetsinbreastcancerpatients ‡A Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients. ‡9 1 | ||
| 919 | ‡a polymorphismintheathookmotifofthetranscriptionalregulatoraknaisariskfactorforcervicalcancer ‡A A polymorphism in the AT-hook motif of the transcriptional regulator AKNA is a risk factor for cervical cancer ‡9 1 | ||
| 919 | ‡a speciesspecificbindingofcd4tothebeta2domainofmajorhistocompatibilitycomplexclass2molecules ‡A Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules ‡9 1 | ||
| 919 | ‡a splicevariantsofzincfingerprotein695mrnaassociatedtoovariancancer ‡A Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer. ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 NII|DA16330503 | ||
| 996 | ‡2 BNC|981058515383806706 | ||
| 996 | ‡2 BNCHL|10000000000000000119138 | ||
| 996 | ‡2 DNB|1056287985 | ||
| 996 | ‡2 DNB|123680379 | ||
| 996 | ‡2 BNE|XX1500764 | ||
| 996 | ‡2 NUKAT|nx2023858903 | ||
| 996 | ‡2 LC|n 80069608 | ||
| 996 | ‡2 LC|n 81083880 | ||
| 996 | ‡2 LC|ns2014000867 | ||
| 996 | ‡2 ISNI|0000000061079788 | ||
| 996 | ‡2 DE633|pe30108481 | ||
| 996 | ‡2 LC|no2008022604 | ||
| 996 | ‡2 DBC|87097991617463 | ||
| 996 | ‡2 BNC|981058513919606706 | ||
| 996 | ‡2 SUDOC|254637752 | ||
| 996 | ‡2 ISNI|000000000249077X | ||
| 996 | ‡2 LC|n 2002037455 | ||
| 996 | ‡2 ISNI|0000000078280306 | ||
| 996 | ‡2 LC|no2006068928 | ||
| 996 | ‡2 ISNI|0000000061150927 | ||
| 996 | ‡2 BNE|XX970374 | ||
| 996 | ‡2 BNE|XX1444186 | ||
| 996 | ‡2 BIBSYS|14029776 | ||
| 996 | ‡2 ISNI|0000000476682714 | ||
| 996 | ‡2 BNCHL|10000000000000000119203 | ||
| 996 | ‡2 SUDOC|032764197 | ||
| 996 | ‡2 BNE|XX1206376 | ||
| 996 | ‡2 BNE|XX1076910 | ||
| 996 | ‡2 BAV|495_221367 | ||
| 996 | ‡2 ISNI|0000000059520079 | ||
| 996 | ‡2 BNE|XX1182980 | ||
| 996 | ‡2 BNE|XX1562299 | ||
| 996 | ‡2 BNCHL|10000000000000000866674 | ||
| 996 | ‡2 NUKAT|n 2005102105 | ||
| 996 | ‡2 BNC|981058614834306706 | ||
| 996 | ‡2 SUDOC|140255885 | ||
| 996 | ‡2 PTBNP|177996 | ||
| 996 | ‡2 BNC|981058528418406706 | ||
| 996 | ‡2 BNC|981058602773906706 | ||
| 996 | ‡2 SUDOC|243387210 | ||
| 996 | ‡2 BNE|XX1648925 | ||
| 996 | ‡2 PTBNP|1489769 | ||
| 996 | ‡2 BNC|981058609099206706 | ||
| 996 | ‡2 LC|n 2019182549 | ||
| 996 | ‡2 BNE|XX1053553 | ||
| 996 | ‡2 BIBSYS|9021710 | ||
| 996 | ‡2 LC|n 2004099908 | ||
| 996 | ‡2 BNE|XX1727472 | ||
| 996 | ‡2 ISNI|0000000039250665 | ||
| 996 | ‡2 ISNI|000000011905690X | ||
| 996 | ‡2 BNCHL|10000000000000000119195 | ||
| 996 | ‡2 LC|n 2016038576 | ||
| 996 | ‡2 LC|no 91013866 | ||
| 996 | ‡2 BNC|981058528418606706 | ||
| 996 | ‡2 BNE|XX1587807 | ||
| 996 | ‡2 BNC|981058518412306706 | ||
| 996 | ‡2 ISNI|0000000077125718 | ||
| 996 | ‡2 DNB|134134796 | ||
| 996 | ‡2 BNE|XX1498855 | ||
| 996 | ‡2 SUDOC|19458061X | ||
| 996 | ‡2 ISNI|0000000117554016 | ||
| 996 | ‡2 SUDOC|031237088 | ||
| 996 | ‡2 LC|no2013088901 | ||
| 996 | ‡2 BNE|XX895475 | ||
| 996 | ‡2 PLWABN|9810564928405606 | ||
| 996 | ‡2 BNCHL|10000000000000000138671 | ||
| 996 | ‡2 BNE|XX1386833 | ||
| 996 | ‡2 DNB|174210264 | ||
| 996 | ‡2 LC|n 95081889 | ||
| 996 | ‡2 BNF|17006884 | ||
| 996 | ‡2 DNB|142169633 | ||
| 996 | ‡2 RERO|A012067722 | ||
| 996 | ‡2 NTA|315597704 | ||
| 996 | ‡2 ISNI|0000000060407575 | ||
| 996 | ‡2 BNE|XX4863217 | ||
| 996 | ‡2 BNF|16209819 | ||
| 996 | ‡2 LC|no2003108617 | ||
| 996 | ‡2 ISNI|000000004726520X | ||
| 996 | ‡2 DNB|132319829 | ||
| 996 | ‡2 BNE|XX6252269 | ||
| 996 | ‡2 LC|no2010169593 | ||
| 996 | ‡2 PTBNP|1084968 | ||
| 996 | ‡2 RERO|A008687570 | ||
| 996 | ‡2 CAOONL|ncf11258494 | ||
| 996 | ‡2 LC|no2009150130 | ||
| 996 | ‡2 SUDOC|144703955 | ||
| 996 | ‡2 BNE|XX859215 | ||
| 996 | ‡2 LC|nr 00010493 | ||
| 996 | ‡2 ISNI|0000000377546530 | ||
| 996 | ‡2 BNE|XX1363729 | ||
| 996 | ‡2 ISNI|0000000120981430 | ||
| 996 | ‡2 DNB|1063393876 | ||
| 996 | ‡2 BNE|XX1079508 | ||
| 996 | ‡2 LC|n 2006092471 | ||
| 996 | ‡2 BNC|981058612360506706 | ||
| 996 | ‡2 BNE|XX844782 | ||
| 996 | ‡2 LC|nr2006023968 | ||
| 996 | ‡2 NYNYRILM|221569 | ||
| 996 | ‡2 ISNI|000000006105429X | ||
| 996 | ‡2 BNE|XX5526219 | ||
| 996 | ‡2 LC|no2013087291 | ||
| 996 | ‡2 LC|no2008038083 | ||
| 996 | ‡2 LC|no2019181810 | ||
| 996 | ‡2 BNE|XX1380286 | ||
| 996 | ‡2 SUDOC|244420394 | ||
| 996 | ‡2 BLBNB|001571787 | ||
| 996 | ‡2 LC|nr 92040384 | ||
| 996 | ‡2 BNF|16964450 | ||
| 996 | ‡2 BIBSYS|14019693 | ||
| 996 | ‡2 LC|no2001010856 | ||
| 996 | ‡2 NKC|mzk2005273175 | ||
| 996 | ‡2 NUKAT|n 2021089367 | ||
| 996 | ‡2 DNB|105618017X | ||
| 996 | ‡2 BNE|XX1728816 | ||
| 996 | ‡2 LC|no2012092639 | ||
| 996 | ‡2 LC|no2007155802 | ||
| 996 | ‡2 LC|no2017001110 | ||
| 996 | ‡2 LC|no2022053734 | ||
| 996 | ‡2 LC|no2018053956 | ||
| 996 | ‡2 BNE|XX1103708 | ||
| 996 | ‡2 DE633|pe30033375 | ||
| 996 | ‡2 PTBNP|1810578 | ||
| 996 | ‡2 ISNI|0000000025259132 | ||
| 996 | ‡2 BNF|12410408 | ||
| 996 | ‡2 BNE|XX1316858 | ||
| 996 | ‡2 LIH|LNB:B__L9;=_z_W | ||
| 996 | ‡2 ISNI|0000000063024094 | ||
| 996 | ‡2 BNE|XX1375665 | ||
| 996 | ‡2 BNE|XX1518172 | ||
| 996 | ‡2 BNCHL|10000000000000000138668 | ||
| 996 | ‡2 ISNI|0000000072461720 | ||
| 996 | ‡2 BNE|XX1039710 | ||
| 996 | ‡2 LC|no2008010116 | ||
| 996 | ‡2 DNB|1253142106 | ||
| 996 | ‡2 LC|nr 92020134 | ||
| 996 | ‡2 BNCHL|10000000000000000164411 | ||
| 996 | ‡2 ISNI|0000000399460615 | ||
| 996 | ‡2 DNB|1317939085 | ||
| 996 | ‡2 BNE|XX1144954 | ||
| 996 | ‡2 BNCHL|10000000000000000151509 | ||
| 996 | ‡2 BNE|XX1097332 | ||
| 996 | ‡2 DNB|140700455 | ||
| 996 | ‡2 ISNI|0000000059722906 | ||
| 996 | ‡2 PTBNP|137692 | ||
| 996 | ‡2 BNE|XX1726872 | ||
| 996 | ‡2 LC|no2021128359 | ||
| 996 | ‡2 LC|nr 96036410 | ||
| 996 | ‡2 BNE|XX1022312 | ||
| 996 | ‡2 LC|nr 91038525 | ||
| 996 | ‡2 DNB|1151947938 | ||
| 996 | ‡2 LC|n 93052973 | ||
| 996 | ‡2 LC|n 89613851 | ||
| 996 | ‡2 ISNI|0000000501587816 | ||
| 996 | ‡2 DNB|1057542083 | ||
| 996 | ‡2 BNC|981058599151306706 | ||
| 996 | ‡2 LC|n 2008022277 | ||
| 996 | ‡2 BNE|XX1655602 | ||
| 996 | ‡2 LC|n 95005079 | ||
| 996 | ‡2 SUDOC|144909898 | ||
| 996 | ‡2 BNE|XX4890428 | ||
| 996 | ‡2 NTA|338643672 | ||
| 996 | ‡2 BNE|XX1048851 | ||
| 996 | ‡2 LC|n 00102897 | ||
| 996 | ‡2 NSK|000478772 | ||
| 996 | ‡2 SUDOC|130779784 | ||
| 996 | ‡2 ISNI|0000000060673531 | ||
| 996 | ‡2 ISNI|0000000060513319 | ||
| 996 | ‡2 LC|n 97117235 | ||
| 996 | ‡2 LC|n 85189609 | ||
| 996 | ‡2 JPG|500261606 | ||
| 996 | ‡2 BNC|981058513889106706 | ||
| 996 | ‡2 ISNI|0000000080151706 | ||
| 996 | ‡2 BNE|XX991250 | ||
| 996 | ‡2 PTBNP|201566 | ||
| 996 | ‡2 LC|no2017030421 | ||
| 996 | ‡2 BNE|XX1184795 | ||
| 996 | ‡2 ISNI|0000000454231146 | ||
| 996 | ‡2 SUDOC|031954987 | ||
| 996 | ‡2 BNE|XX1093976 | ||
| 996 | ‡2 SUDOC|072808691 | ||
| 996 | ‡2 LC|no2017052827 | ||
| 996 | ‡2 SUDOC|186406657 | ||
| 996 | ‡2 NTA|419576061 | ||
| 996 | ‡2 DNB|1079566821 | ||
| 996 | ‡2 NTA|245830383 | ||
| 996 | ‡2 NTA|06922840X | ||
| 996 | ‡2 ISNI|0000000081319662 | ||
| 996 | ‡2 ISNI|0000000060421350 | ||
| 996 | ‡2 SUDOC|070160317 | ||
| 996 | ‡2 LC|no2009080775 | ||
| 996 | ‡2 DNB|128548517 | ||
| 996 | ‡2 BNE|XX1574990 | ||
| 996 | ‡2 DNB|1026810825 | ||
| 996 | ‡2 LC|no2002023419 | ||
| 996 | ‡2 BNE|XX1074817 | ||
| 996 | ‡2 LC|n 85109606 | ||
| 996 | ‡2 BNE|XX1645135 | ||
| 996 | ‡2 DNB|1057665878 | ||
| 996 | ‡2 BNE|XX5017425 | ||
| 996 | ‡2 NSK|000294506 | ||
| 996 | ‡2 BNE|XX883497 | ||
| 996 | ‡2 ARBABN|000069555 | ||
| 996 | ‡2 RERO|A016274968 | ||
| 996 | ‡2 BIBSYS|59922 | ||
| 996 | ‡2 BNF|16978156 | ||
| 996 | ‡2 ISNI|0000000426001570 | ||
| 996 | ‡2 BNE|XX1220629 | ||
| 996 | ‡2 ISNI|0000000116103141 | ||
| 996 | ‡2 BNE|XX5399421 | ||
| 996 | ‡2 SUDOC|267764111 | ||
| 996 | ‡2 CAOONL|ncf11548860 | ||
| 996 | ‡2 ISNI|0000000514227254 | ||
| 996 | ‡2 ISNI|0000000059594932 | ||
| 996 | ‡2 BNE|XX5457491 | ||
| 996 | ‡2 NTA|251227944 | ||
| 996 | ‡2 RERO|A026623020 | ||
| 996 | ‡2 SUDOC|228275245 | ||
| 996 | ‡2 J9U|987011946174405171 | ||
| 996 | ‡2 LC|n 88268638 | ||
| 996 | ‡2 RERO|A003609015 | ||
| 996 | ‡2 ISNI|0000000080172101 | ||
| 996 | ‡2 ISNI|0000000059684022 | ||
| 996 | ‡2 ISNI|0000000117789034 | ||
| 996 | ‡2 LC|no2019094068 | ||
| 996 | ‡2 BLBNB|001416727 | ||
| 996 | ‡2 ISNI|000000008017684X | ||
| 996 | ‡2 BNC|981058511881306706 | ||
| 996 | ‡2 NUKAT|n 2008130772 | ||
| 996 | ‡2 JPG|500338715 | ||
| 996 | ‡2 NTA|314603239 | ||
| 996 | ‡2 DNB|174358539 | ||
| 996 | ‡2 BNE|XX5207781 | ||
| 996 | ‡2 ISNI|0000000079787854 | ||
| 996 | ‡2 SUDOC|147928869 | ||
| 996 | ‡2 LC|n 96005202 | ||
| 996 | ‡2 BNE|XX824965 | ||
| 996 | ‡2 NUKAT|n 2012109200 | ||
| 996 | ‡2 BNE|XX1586571 | ||
| 996 | ‡2 BNE|XX1402548 | ||
| 996 | ‡2 LC|no2005079333 | ||
| 996 | ‡2 ISNI|000000005135941X | ||
| 996 | ‡2 DNB|1057488437 | ||
| 996 | ‡2 ISNI|0000000385362942 | ||
| 996 | ‡2 ISNI|0000000060970843 | ||
| 996 | ‡2 ISNI|0000000079697218 | ||
| 996 | ‡2 BNE|XX1163068 | ||
| 996 | ‡2 SUDOC|145646564 | ||
| 996 | ‡2 ISNI|0000000060028575 | ||
| 996 | ‡2 BNE|XX1238466 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 | ||
| 998 | ‡a Moreno, José ‡2 PLWABN|9810567120105606 ‡3 title: (0.96, 'enhancedhealingandantiinflammatoryeffectsofacarbohydratepolymerwithzincoxideinpatientswithchronicvenouslegulcers', 'enhancedhealingandantiinflammatoryeffectsofacarbohydratepolymerwithzincoxideinpatientswithchronicvenouslegulcerspreliminaryresults') ‡3 viafid |
